Cerep

128 rue Danton,
BP 50601,
92506 Rueil-Malmaison cedex
France
Tel: 33 1 55 94 84 00
Fax: 33 1 55 94 84 10

Print Email to a friend

Cerep offers a range of tests for rapid, precise evaluation of the pharmaceutical properties of leads. The early ADME Profile provides useful bioavailability information, which combined with pharmacology profiling data help to optimize drug candidate selection. The combination of the early ADME profile with either the ExpresSProfile (50 receptors) or HTP (75 receptors) is a rapid, cost effective way to prioritize drug candidates.

Further Information: http://www.cerep.fr


Related news from our archive

Cerep and Servier Establish new Collaboration Agreement for Drug Discovery and Lead Optimization
Servier to identify targets of interest for Cerep’s collection of compounds while Cerep will run high throughput screenings on Servier library.

Cerep and Servier Establish a new Collaboration Agreement for Drug Discovery and Lead Optimization
Cerep announces the signature with Servier of a 3-year collaboration agreement for the discovery and optimization of new drugs.

Cerep Announces the Extension of its Pharmaco-Informatics Alliance with Pfizer
The goal of the collaboration is to provide early tools for in vitro safety evaluation of lead compounds.

Cerep and Servier Establish new Collaboration Agreement for Drug Discovery and Lead Optimization
Servier to identify targets of interest for Cerep’s collection of compounds while Cerep will run high throughput screenings on Servier library.

Cerep and Servier Establish a new Collaboration Agreement for Drug Discovery and Lead Optimization
Cerep announces the signature with Servier of a 3-year collaboration agreement for the discovery and optimization of new drugs.

Cerep Announces the Extension of its Pharmaco-Informatics Alliance with Pfizer
The goal of the collaboration is to provide early tools for in vitro safety evaluation of lead compounds.